Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Impact Education, LLC, in collaboration with Postgraduate Institute for Medicine.

This activity is supported by independent educational grants from AbbVie, Inc., Celgene Corporation, and Novartis Pharmaceuticals Corporation.

Coming Soon

This live webcast is now available as an on-demand CE activity. For more information and to participate, go to: www.ImpactEdu.net/PsoriaticDisease/

DISTINGUISHED FACULTY PRESENTERS

	Robin Dore, MD Clinical Professor of Medicine David Geffen School of Medicine at UCLA		Jeffrey Dunn, PharmD, MBA Senior Vice President Chief Clinical Officer VRx/MagellanRx
	John Knispel, MD, CPE, FACOG Regional Medical Director (Ret) Commercial Markets Florida Humana, Inc.		Alan Menter, MD Chief, Division of Dermatology Baylor University Medical Center
	Paul Yamauchi, MD, PhD Clinical Assistant Professor of Dermatology David Geffen School of Medicine at UCLA Adjunct Associate Professor John Wayne Cancer Institute Dermatology Institute & Skin Care Center, Inc. Clinical Science Institute

WHO SHOULD ATTEND?

This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, pharmacy directors, specialty pharmacists, quality directors, care managers, registered nurses, and other managed care and payer organization professionals.

STATEMENT OF NEED / PROGRAM OVERVIEW

Psoriasis is one of the most common autoimmune diseases to develop in genetically susceptible individuals with an estimated 7.5 million Americans afflicted by psoriasis; and psoriatic arthritis is considered to be one of the most disabling types of arthritis affecting as many as 2.3 million Americans. Direct annual health care costs assigned to the management of psoriatic disease is estimated to be as high as $2.0-3.0 billion. As novel agents become available, treatment decision making is becoming more complex and managed care professionals need to appropriately and effectively design benefits that optimize both cost-efficiency and patient outcomes. The expert faculty panel will present the latest clinical data to recommend appropriate therapies, utilize comparative effectiveness research (CER), design appropriate medical and pharmacy benefits, and implement health care quality measures. Emerging clinical and economic techniques, practical examples, and expert recommendations will be formulated to illuminate key learnings using psoriatic disease as the therapeutic area of focus.

EDUCATIONAL OBJECTIVES

At the conclusion of this activity, participants should be able to demonstrate improved ability to: Assess current and emerging therapies for the treatment of psoriasis and psoriatic arthritis and cite their clinical trial data. Review the comparative effectiveness research (CER) framework and discuss application of CER findings to benefit design and clinical decision making for patients with psoriatic disease. Identify barriers to adherence and formulate strategies to overcome them. Integrate interventions to coordinate health plan and affiliated provider's efforts in the health care reform era that will lead to better outcomes for patients with psoriasis and psoriatic arthritis.

AGENDA

Presentation Live Webcast 1: June 29 1 PM - 2:30 PM Live Webcast 2: September 13 1 PM - 2:30 PM Live Webcast 3: October 3 1 PM - 2:30 PM Live Webcast 4: October 26 1 PM - 2:30 PM Pre-Activity Learning Assessment and Opening Comments Jeffrey Dunn, PharmD, MBA The Expanding Treatment Armamentarium and Evolving Clinical Guidelines Paul Yamauchi, MD, PhD Robin Dore, MD Alan Menter, MD Robin Dore, MD Paul Yamauchi, MD, PhD Robin Dore, MD Comparative Analyses of Current and Emerging Treatment Options John Knispel, MD, CPE, FACOG Benefit Designs and Care Management Strategies in a Changing Environment Jeffrey Dunn, PharmD, MBA Audience Question and Answer Session Key Takeaways and Closing Comments Post-Activity Assessment and Evaluation All

ACCREDITATION STATEMENTS

Physician Continuing Medical Education This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Impact Education, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Pharmacy Continuing Education

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation This program has been assigned ACPE Universal Activity Number 0797-9999-17-040-L01-P. This program is designated for up to 1.5 contact hours (0.15 CEUs) of continuing pharmacy education credit. Type of Activity: Application For Pharmacists: Upon receipt of a completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks. Nursing Continuing Education Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Credit Designation 1.5 contact hours may be earned for successful completion of this activity. A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you.

Disclosure of Conflicts of Interest The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity. Hardware/Software Requirements Compatible with Internet Explorer 6 and up, Mozilla Firefox 3 and up, Safari 4.0, and Google Chrome 10 and up. Policy on Privacy and Confidentiality Please see final activity for the policy on privacy and confidentiality that relates to this internet activity. Fee Information There is no fee for this educational activity. Policy on Privacy and Confidentiality Please see final activity for the policy on privacy and confidentiality that relates to this internet activity. If you have any questions, please call (215) 619-8812 or email info@impactedu.net.